HMG CoA reductase inhibitors
Beta-hydroxy-β-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (HMG CoA RIs) are now being prescribed in many different countries, and the number of patients treated with these compounds is estimated to be over 1.5 million. The spectrum of indications for these drugs is enlarging. Thus, not...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 1994
|
| In: |
Current opinion in lipidology
Year: 1994, Jahrgang: 5, Heft: 1, Pages: 59-68 |
| ISSN: | 1473-6535 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-lipidology/abstract/1994/02000/hmg_coa_reductase_inhibitors.10.aspx
|
| Verfasserangaben: | Giso Feussner |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1915996511 | ||
| 003 | DE-627 | ||
| 005 | 20250716225412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250130s1994 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1915996511 | ||
| 035 | |a (DE-599)KXP1915996511 | ||
| 035 | |a (OCoLC)1528017357 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Feussner, Giso |e VerfasserIn |0 (DE-588)1111522685 |0 (DE-627)865591776 |0 (DE-576)476134900 |4 aut | |
| 245 | 1 | 0 | |a HMG CoA reductase inhibitors |c Giso Feussner |
| 264 | 1 | |c February 1994 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.01.2025 | ||
| 520 | |a Beta-hydroxy-β-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (HMG CoA RIs) are now being prescribed in many different countries, and the number of patients treated with these compounds is estimated to be over 1.5 million. The spectrum of indications for these drugs is enlarging. Thus, not only patients with primary hypercholesterolemia are suitable candidates for therapy with HMG CoA RIs, but also patients with other forms of familial and non-familial (secondary) dyslipidemias. The safety and tolerance profile is remarkably good and adverse effects tend to be mild and rare. Currently, several primary and secondary intervention trials are ongoing or in preparation to investigate the influence of HMG CoA RIs on cardiovascular morbidity and mortality. | ||
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in lipidology |d London : Lippincott Williams & Wilkins, 1990 |g 5(1994), 1, Seite 59-68 |h Online-Ressource |w (DE-627)324455925 |w (DE-600)2026990-0 |w (DE-576)093981163 |x 1473-6535 |7 nnas |a HMG CoA reductase inhibitors |
| 773 | 1 | 8 | |g volume:5 |g year:1994 |g number:1 |g pages:59-68 |g extent:10 |a HMG CoA reductase inhibitors |
| 856 | 4 | 0 | |u https://journals.lww.com/co-lipidology/abstract/1994/02000/hmg_coa_reductase_inhibitors.10.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250130 | ||
| 993 | |a Article | ||
| 994 | |a 1994 | ||
| 998 | |g 1111522685 |a Feussner, Giso |m 1111522685:Feussner, Giso |d 910000 |d 910100 |e 910000PF1111522685 |e 910100PF1111522685 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1915996511 |e 4659238059 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Giso Feussner"]},"origin":[{"dateIssuedKey":"1994","dateIssuedDisp":"February 1994"}],"id":{"eki":["1915996511"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"title":[{"title_sort":"Current opinion in lipidology","title":"Current opinion in lipidology"}],"pubHistory":["1.1990 -"],"part":{"pages":"59-68","issue":"1","year":"1994","extent":"10","volume":"5","text":"5(1994), 1, Seite 59-68"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 17.10.05"],"disp":"HMG CoA reductase inhibitorsCurrent opinion in lipidology","language":["eng"],"recId":"324455925","origin":[{"publisherPlace":"London ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1990-","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1990"}],"id":{"eki":["324455925"],"zdb":["2026990-0"],"issn":["1473-6535"]},"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"given":"Giso","family":"Feussner","role":"aut","roleDisplay":"VerfasserIn","display":"Feussner, Giso"}],"title":[{"title_sort":"HMG CoA reductase inhibitors","title":"HMG CoA reductase inhibitors"}],"note":["Gesehen am 30.01.2025"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1915996511","language":["eng"]} | ||
| SRT | |a FEUSSNERGIHMGCOAREDU1994 | ||